---
category: news
title: "Castle Biosciences Publishes DecisionDx®-Melanoma Study on the Validation of the i31-GEP SLNB Artificial Intelligence Algorithm"
excerpt: "Castle announced the publication of a study validating performance of the i31-SLNB algorithm to determine sentinel lymph node biopsy positivity risk."
publishedDateTime: 2021-11-06T01:00:00Z
originalUrl: "https://www.businesswire.com/news/home/20211105005811/en/Castle-Biosciences-Publishes-DecisionDx®-Melanoma-Study-on-the-Validation-of-the-i31-GEP-SLNB-Artificial-Intelligence-Algorithm"
webUrl: "https://www.businesswire.com/news/home/20211105005811/en/Castle-Biosciences-Publishes-DecisionDx®-Melanoma-Study-on-the-Validation-of-the-i31-GEP-SLNB-Artificial-Intelligence-Algorithm"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "xRUKdkRriHmAFpcAMbQOaYy7C9kAf+nlGifrNFqHzkpI8TWLkqNL4OP8/bw3NXh6XZjg4ChbxU9afheBERqLwHCzV7c7d0zttdDMll4+FazFy6gkbke8Ld41dGh/pnKuOZ8QK4+Fmzbo/MuLcfY1enEDgeeHosuQvPW1uVqvOnP6iY90oOaaHPT7T1O9vFxRUqeeu2uj3PnSGJpXtM2EMwrR/MCqnN2Btkhgz/YzJl/+xwcWLjDJ7QrXg+hSu5JwXBUd8QQMnl2MTjFh8rz9Ig+ZYUZl3mIWzs861L3zJ7TPnJHebBJRy8KekHEjZHMmxUvcpmcoGk6S93VAYA9d2gKvUkMYokTuwyy87yVum5c=;ry6YQ2yow29mXfP94f/BTQ=="
---

